Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma. Tao L, Miao R, Mekhail T, Sun J, et al. Clin Lung Cancer 2021;22:e506-e511.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tao L, Miao R, Mekhail T, Sun J, et al. Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma. Clin Lung Cancer 2021;22:e506-e511.
PMID: 32807653